|
|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 1 to 5 of 5
| Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | | article | Sho, Takuya; Suda, Goki; Yamamoto, Yoshiya; Furuya, Ken; Baba, Masaru; Ogawa, Koji; Kubo, Akinori; Tokuchi, Yoshimasa; Fu, Qingjie; Yang, Zijian; Kimura, Megumi; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Takagi, Tomofumi; Ito, Jun; Kobayashi, Tomoe; Miyagishima, Takuto; Sakamoto, Naoya | Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150 | - | Cancers | - | 15-Aug-2022 |
| article (author version) | Nakai, Masato; Ogawa, Koji; Takeda, Rei; Ohara, Masatsugu; Kawagishi, Naoki; Izumi, Takaaki; Umemura, Machiko; Ito, Jun; Sho, Takuya; Suda, Goki; Morikawa, Kenichi; Sakamoto, Naoya | Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis | Predictive factors of tolvaptan efficacy for LC | Hepatology Research | - | Feb-2018 |
| article (author version) | Sugiura, Ryo; Naruse, Hirohito; Yamato, Hiroaki; Kudo, Taiki; Yamamoto, Yoshiya; Hatanaka, Kazuteru; Ito, Jun; Kinoshita, Kenji; Miyamoto, Shuichi; Higashino, Masayuki; Hayasaka, Shuhei; Sakamoto, Naoya | Long-term outcomes and risk factors of recurrent biliary obstruction after permanent endoscopic biliary stenting for choledocholithiasis in high-risk patients | - | Journal of Digestive Disease | - | Apr-2020 |
| article | Hosoda, Shunichi; Suda, Goki; Sho, Takuya; Ogawa, Koji; Kimura, Megumi; Yang, Zijian; Yoshida, Sonoe; Kubo, Akinori; Tokuchi, Yoshimasa; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Morikawa, Kenichi; Furuya, Ken; Baba, Masaru; Yamamoto, Yoshiya; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Ito, Jun; Miyagishima, Takuto; Sakamoto, Naoya | Low baseline CXCL9 predicts early progressive disease in unresectable HCC with atezolizumab plus bevacizumab treatment | - | Liver Cancer | - | Jun-2023 |
| article | Sho, Takuya; Nakanishi, Mitsuru; Morikawa, Kenichi; Ohara, Masatsugu; Kawagishi, Naoki; Izumi, Takaaki; Umemura, Machiko; Ito, Jun; Nakai, Masato; Suda, Goki; Ogawa, Koji; Chuma, Makoto; Meguro, Takashi; Nakamura, Michio; Nagasaka, Atsushi; Horimoto, Hiromasa; Yamamoto, Yoshiya; Sakamoto, Naoya | A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma | - | Drugs in R&D | - | Sep-2017 |
Showing results 1 to 5 of 5
|
